Cases & Deals

  • Home
  • Practices
  • Athersys completes registered direct offering of Common Stock

Share

Athersys completes registered direct offering of Common Stock

February 2011

Client(s) Athersys, Inc.

Jones Day advised Athersys, Inc., a clinical stage biopharmaceutical company, in connection with its sale of 4,366,667 shares of Common Stock and Warrants to purchase an additional 1,310,000 shares of Common Stock in a registered direct offering.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.